These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 35914624)

  • 21. The therapeutic potential of nociceptin/orphanin FQ receptor agonists as analgesics without abuse liability.
    Lin AP; Ko MC
    ACS Chem Neurosci; 2013 Feb; 4(2):214-24. PubMed ID: 23421672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of mu and delta opioid receptors to the pharmacological profile of kappa opioid receptor subtypes.
    Brissett DI; Whistler JL; van Rijn RM
    Eur J Pain; 2012 Mar; 16(3):327-37. PubMed ID: 22337177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats.
    Burke NN; Ferdousi M; Deaver DR; Finn DP; Roche M; Kelly JP
    Neuropharmacology; 2019 Mar; 146():327-336. PubMed ID: 30553825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
    Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
    J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A role for the mu opioid receptor in the antidepressant effects of buprenorphine.
    Robinson SA; Erickson RL; Browne CA; Lucki I
    Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics.
    McLaughlin JP; Rayala R; Bunnell AJ; Tantak MP; Eans SO; Nefzi K; Ganno ML; Dooley CT; Nefzi A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue.
    Petrocelli G; Pampanella L; Abruzzo PM; Ventura C; Canaider S; Facchin F
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delta and kappa opioid receptors in human endometrium during the menstrual cycle: Expression and localization.
    Olabarrieta E; Totorikaguena L; Matorras R; Agirregoitia E; Agirregoitia N
    Eur J Obstet Gynecol Reprod Biol; 2023 Apr; 283():68-73. PubMed ID: 36801594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional Opioid Ligands.
    Anand JP; Montgomery D
    Handb Exp Pharmacol; 2018; 247():21-51. PubMed ID: 29675582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence.
    Lutz PE; Ayranci G; Chu-Sin-Chung P; Matifas A; Koebel P; Filliol D; Befort K; Ouagazzal AM; Kieffer BL
    Neuropsychopharmacology; 2014 Oct; 39(11):2694-705. PubMed ID: 24874714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities.
    Keasling AW; Pandey P; Doerksen RJ; Pedrino GR; Costa EA; da Cunha LC; Zjawiony JK; Fajemiroye JO
    J Psychopharmacol; 2019 Jul; 33(7):865-881. PubMed ID: 31192780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonist.
    Gassaway MM; Rives ML; Kruegel AC; Javitch JA; Sames D
    Transl Psychiatry; 2014 Jul; 4(7):e411. PubMed ID: 25026323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The opioidergic system in the combined regulation of pain and immunity].
    Zakharova LA; Vasilenko AM
    Izv Akad Nauk Ser Biol; 2001; (3):339-52. PubMed ID: 11433945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
    Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
    Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite effects of mu and delta opioid receptor agonists on excitatory propagation induced in rat somatosensory and insular cortices by dental pulp stimulation.
    Yokota E; Koyanagi Y; Nakamura H; Horinuki E; Oi Y; Kobayashi M
    Neurosci Lett; 2016 Aug; 628():52-8. PubMed ID: 27246300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for nociceptin/orphanin FQ (NOP) but not µ (MOP), δ (DOP) or κ (KOP) opioid receptor mRNA in whole human blood.
    Al-Hashimi M; McDonald J; Thompson JP; Lambert DG
    Br J Anaesth; 2016 Mar; 116(3):423-9. PubMed ID: 26865135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
    Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Delta-Opioid Receptor Bidirectionally Modulates Itch.
    Smith KM; Nguyen E; Ross SE
    J Pain; 2023 Feb; 24(2):264-272. PubMed ID: 36464136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
    Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
    Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.